Arachidonic acid monooxygenase: Genetic and biochemical approaches to physiological/pathophysiological relevance

Prostaglandins and Other Lipid Mediators

Volumn 120, Issue , 2015, Pages 40-49

  Capdevila, Jorge H ^a   Wang, Wenhui ^b   Falck, John R ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

20 HETE; Arachidonic acid; EET; Epoxygenase; Hypertension; P450

Indexed keywords

ANDROGEN; ARACHIDONIC ACID DERIVATIVE; ARACHIDONIC ACID MONOOXYGENASE; CYTOCHROME P450 2C; CYTOCHROME P450 2C44; CYTOCHROME P450 2C8; CYTOCHROME P450 4A; CYTOCHROME P450 4A10; CYTOCHROME P450 4A11; CYTOCHROME P450 4A14; EPITHELIAL SODIUM CHANNEL; EPOXYICOSATRIENOIC ACID; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE; ARACHIDONATE EPOXYGENASE; CYTOCHROME P450; SODIUM;

ARTICLE; BLOOD PRESSURE REGULATION; DOWN REGULATION; HUMAN; HYPERTENSION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SODIUM ABSORPTION; SODIUM EXCRETION; SODIUM RESTRICTION; UPREGULATION; ANIMAL; BLOOD PRESSURE; ENZYMOLOGY; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; CYTOCHROME P-450 ENZYME SYSTEM; EPITHELIAL SODIUM CHANNELS; HUMANS; HYPERTENSION; SODIUM;

EID: 84941811497     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2015.05.004     Document Type: Review

References (75)

1. J.H. Capdevila, J.R. Falck, and R.C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase J Lipid Res 41 2000 163 181 and cited references
2. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 2002 131 185 and cited references
3. S.L. Pfister, K.M. Gauthier, and W.B. Campbell Vascular pharmacology of epoxyeicosatrienoic acids Adv Pharmacol 60 2010 1 33 and cited references
4. A.A. Spector, X. Fang, G.D. Snyder, and N.L. Weintraub Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function Prog Lipid Res 43 2004 55 90 and cited references
5. J.H. Capdevila, J.R. Falck, and J.D. Imig Roles of cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension Kidney Int 72 2007 683 689 and cited references
6. J.H. Capdevila Regulation of ion transport and blood pressure by cytochrome P450 moooxygenases Curr Opin Nephrol Hypertens 16 2007 465 470 and cited references
7. C.C. Wu, T. Gupta, V. Garcia, Y. Ding, and M.L. Schwartzman 20-HETE and blood pressure regulation. Clinical implications Cardiol Rev 22 2014 1 12 and cited references
8. N. Chacos, J. Capdevila, J.R. Falck, S. Manna, C. Wixtrom, S.S. Gill, and et al. The reaction of arachidonic acid epoxides with a cytosolic epoxide hydrolase Arch Biochem Biophys 223 1983 639 648
9. D.C. Zeldin, J. Kobayashi, J.R. Falck, B.S. Winder, B.D. Hammock, J.R. Snapper, and et al. Regio and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase J Biol Chem 268 1993 6402 6407
10. J.D. Imig Epoxides and soluble epoxide hydrolase in cardiovascular physiology Physiol Rev 92 2012 101 130 and cited references
11. C. Morisseau, and B.D. Hammock Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health Ann Rev Pharmacol Toxicol 53 2013 37 58 and cited references
12. A. Karara, K. Makita, H.R. Jacobson, and et al. Molecular cloning, expression and enzymatic characterization of the rat kidney cytochrome P450 arachidonic acid epoxygenase J Biol Chem 268 1993 13565 13570
13. T.C. DeLozier, C.C. Tsao, S.J. Coulter, and et al. CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products J Pharmacol Exp Ther 310 2004 845 854
14. V.R. Holla, K. Makita, P.G. Zaphiropoulus, and J.H. Capdevila The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading J Clin Invest 104 1999 751 760
15. K. Makita, K. Takahashi, A. Karara, H.R. Jacobson, J.R. Falck, and J.H. Capdevila Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet J Clin Invest 94 1994 2414 2420
16. J.C. McGiff Cytochrome P-450 metabolism of AA Annu Rev Pharmacol Toxicol 31 1991 339 369 and references therein
17. M.H. Wang, H. Guan, X. Nguyen, B.A. Zand, A. Nasjletti, and M.L. Schwartzman Contribution of Cytochrome P450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys Am J Physiol. Renal Physiol 276 1999 F247 F253
18. V.R. Holla, F. Adas, J.D. Imig, and et al. Alterations in the regulation of androgen-sensitive Cyp4a monooxygenases cause hypertension Proc Natl Acad Sci USA 98 2001 5211 5216
19. K. Athirakul, J.A. Bradbury, J.P. Graves, and et al. Increased blood pressure in mice lacking cytochrome P450 2J5 FASEB J 22 2008 4096 4108
20. K. Nakagawa, V.R. Holla, Y. Wei, and et al. Salt sensitive hypertension is associated with a dysfunctional Cyp4a10 gene and kidney epithelial sodium channel J Clin Invest 116 2006 1696 1702
21. S.A. Bardowell, F. Duan, D. Manor, J.E. Swanson, and R.S. Parker Disruption of mouse cytochrome P450 4f4 (Cyp4f4 gene) causes severe perturbations in vitamin E metabolism J Biol Chem 287 2012 26077 32608
22. J.H. Capdevila, N. Pidkovka, S. Mei, and et al. The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increase dietary salt J Biol Chem 289 2014 4377 4386
23. A. Pozzi, V. Popescu, S. Yang, and et al. The anti-tumorigenic properties of the peroxisomal proliferator-activated receptor α are arachidonic acid epoxygenase mediated J Biol Chem 285 2010 12840 12850
24. D.N. Muller, C. Schmidt, E. Barbosa-Sicard, and et al. Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation Biochem J 403 2007 109 118
25. A. Bellamine, Y. Wang, M. Waterman, and et al. Characterization of the CYP4A11 gene, a second CYP4A gene in humans Arch Biochem Biophys 409 2003 221 227
26. J.V. Gainer, A. Bellamine, E. Dawson, and et al. A functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension Circulation 111 2005 63 69
27. C.C. Wu, S. Mei, J. Cheng, and et al. Androgen sensitive hypertension associated with upregulated vascular CYP4A12-20-HETE synthase J Am Soc Nephrol. 24 2013 1288 1296
28. R. Quigley, S. Chakravarty, X. Zhao, J.D. Imig, and J.H. Capdevila Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout mice Nephron Physiol 113 2009 23 28
29. Y. Wei, D.H. Lin, R. Kemp, and et al. Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase dependent pathways J Gen Physiol 124 2004 719 727
30. E.F. Johnson, M.H. Hsu, U. Savas, and K.J. Griffin Regulation of P450 4A expression by peroxisomal proliferator activates receptors Toxicology 181-182 2002 203 206 and cited references
31. J.C. Corton, L.-Q. Fan, S. Brown, and et al. Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals Mol Pharm 54 1998 463 473
32. B. Mayer, W.Q. Lieb, A. Gotz, and et al. Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg Echocardiographic Substudy Hypertension 46 2005 766 771
33. C. Lacks, L. Cardenas, A. Devos, A. Toure, J. Cardenas-Garcia, and A. Kenani Arachidonic acid γ-hydroxylase CYP4A11: inter-ethnic variations in the 8590T>C loss-of-function variant Mol Biol Rep 39 2012 1503 1508
34. J.Q. Liang, M.R. Yan, L. Yang, Q. Suyila, H.W. Cui, and X.L. Su Association of a CYP4A11 polymorphism and hypertension in the Mongolian and Ham populations of China Genet Mol Res 13 2014 508 517
35. J.S. Williams, P.N. Hopkins, X. Jeunemaitre, and N.J. Brown CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow J Hypertens 29 2011 1913 1918
36. C.C. Tsao, S.J. Coulter, A. Chien, and et al. Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to region- and stereoselective products J Pharmacol Exp Ther 310 2001 845 854
37. D.C. Zeldin, R.N. DuBois, J.R. Falck, and J.H. Capdevila Molecular cloning and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform Arch Biochem Biophys 322 1995 76 86
38. J.D. Imig, A. Elmarakby, K. Nithipatikom, S. Wei, J.H. Capdevila, and V.R. Tuniki Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actions Front Physiol 1 2010 1 8
39. R.P. Lifton, A.G. Gharavi, and D.S. Geller Molecular mechanisms of human hypertension Cell 104 2001 545 556
40. W.H. Wang, C. Zhang, D.H. Lin, and et al. Cyp-epoxygenase in the connecting tubule(CNT)/cortical collecting duct (CCD) is essential for high potassium (K) intake-induced antihypertensive effect Am J Physiol Renal Physiol 307 2014 F453 F460
41. J.H. Capdevila, and W.H. Wang Role of cytochrome P450 epoxygenase in regulating renal membrane transport and hypertension Curr Opin Nephrol Hypertens 22 2013 163 169 and cited references
42. P. Meneton, J. Loffing, and D.G. Warnock Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule Am J Physiol Renal Physiol 287 2004 F593 F601 and cited references
43. I. Rubera, J. Loffing, L.G. Palmer, G. Frindt, N. Fowler-Jaeger, and D. Sauter Collecting duct-specific gene inactivation of αENaC in the mouse kidney does not impair sodium and potassium balance J Clin Invest 112 2003 554 565
44. + homeostasis and hypertension Endocr Rev 23 2002 258 275
45. H. Shi, C. Asher, A. Chigaev, and et al. Interactions of β and ENaC with Nedd4 can be facilitated by an ERK-mediated phosphorylation J Biol Chem 277 2002 13539 13547
46. J.P. Shen, and C.U. Cotton Epidermal growth factor inhibits amiloride-sensitive sodium absorption in renal collecting duct cells Am J Physiol Renal Physiol 284 2003 F57 F64
47. Y.H. Zhang, D. Alvarez de la Rosa, C.M. Canessa, and J.P. Hayslett Insulin-induced phosphorylation of ENaC correlates with increased sodium channel function in A6 cells Am J Physiol Cell Physiol 288 2005 C141 C147
48. + channel by cleavage J Biol Chem 284 2009 36334 36345
49. M.B. Butterworth, O.A. Weisz, and J.P. Johnson Some assembly required. Putting the epithelial sodium channel together J Biol Chem 283 2008 35305 35309
50. M.B. Butterwork, R.S. Edinger, R.A. Fizzel, and J.P. Johnson Regulation of epithelial sodium channel by membrane trafficking Am J Physiol Renal Physiol 296 2009 F10 F24
51. L.L. Hamm, Z. Feng, and K.S. Hering-Smith Regulation of sodium transport by ENaC in the kidney Curr Opin Nephrol Hypertens 19 2010 98 105 and cited references
52. J.K. Chen, D.-W. Wang, J.R. Falck, J.H. Capdevila, and R.C. Harris Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicated that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor J Biol Chem 274 1999 4764 4769
53. J.K. Chen, J.H. Capdevila, and R.C. Harris Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells Proc Natl Acad Sci USA 99 2002 6029 6034
54. R.A. Falin, and C.U. Cotton Acute downregulation of ENaC by EGF involves the PY motif and putative ERK phosphorylation site J Gen Physiol 130 2007 313 328
55. N. Pidkovka, R. Rao, S. Mei, and et al. Epoxyeicosatrienoic acids (EETs) regulate epithelial sodium channel activity by extracellular signal- regulated kinase 1/2 (ERK1/2)-mediated phosphorylation J Biol Chem 288 2013 5223 5231
56. N. Skrypnyk, X. Chen, W. Hu, and et al. Activation of peroxisomal proliferator activated receptor (PPAR)α is beneficial for the prevention and treatment of non-small cell lung cancer Cancer Res 74 2013 621 631
57. Y.F. Chen, and Q.C. Meng Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent Life Sci 48 1991 85 96 and cited references
58. J.F. Reckelhoff Gender differences in the regulation of blood pressure Hypertension 37 2001 1199 1208 and cited references
59. D.S. Riddick, C. Lee, A. Bathena, and et al. Transcriptional regulation of cytochrome P45 genes by endogenous and exogenous chemicals Drug Metab Dispos 32 2004 367 375 and cited references
60. L.A. Cowart, S. Wei, M.H. Hsu, and et al. The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisomal proliferator-activated receptor ligands J Biol Chem 277 2002 35105 35112
61. K.R. Schmelzer, L. Kubala, J.W. Newman, I.H. Kim, J.P. Eiserich, and B.D. Hammock Soluble epoxide hydrolase is a therapeutical target for acute inflammation Proc Natl Acad Sci USA 102 2005 9772 9777
62. N. Chiamvimonvat, C.M. Ho, H.J. Tsai, and B.D. Hammock The soluble epoxide hydrolase as a pharmaceutical target for hypertension J Cardiovasc Pharmacol 50 2007 225 237
63. F.P. Guengerich Cytochrome P450s and other enzymes in drug metabolism and toxicity AAPS J 8 2006 101 111 and cited references
64. P.Y.-K. Wong, P.-S. Lai, S.-Y. Shen, Y.Y. Belosludtsev, and J.R. Falck Post-receptor signal transduction and regulation of 14(R), 15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells J Lipid Mediators Cell Signal 16 1997 155 169
65. P.Y.-K. Wong, P.-S. Lai, and J.R. Falck Mechanism and signal transduction of 14(R), 15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes Prostag Other Lipid Med 62 2000 321 333
66. A. Karara, E. Dishman, J.R. Falck, and J.H. Capdevila Endogenous epoxyeicosatrienoyl-phospholipids: a novel class of cellular glycerolipids containing epoxidized arachidonate moieties J Biol Chem 266 1991 7561 7569
67. J.K. Chen, J. Chen, J.D. Imig, S. Wei, D.L. Hachey, J.S. Guthi, and et al. Identification of novel endogenous cytochrome P450 arachidonate metabolites with high affinity for cannabinoid receptors J Biol Chem 283 2008 24514 24524
68. T.R. Harris, and B.D. Hammock Soluble epoxide hydrolase: gene structure, expression and deletion Gene 526 2013 61 74
69. A. Cronin, S. Mowbray, H. Durk, S. Homburg, I. Fleming, and B. Fisslthaler The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase Proc Natl Acad Sci USA 100 2003 1552 1557
70. A.E. EnayetAllah, A. Luria, B. Luo, H.-J. Tsai, P. Sura, B.D. Hammock, and et al. Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase J Biol Chem 283 2008 36592 36598
71. A. Oguro, and S. Imaoka Lysophosphatidic acids are new substrates for the phosphatase domain of soluble epoxide hydrolase J Lipid Res 53 2012 505 512
72. H.-H. Hou, B.D. Hammock, K.-H. Su, and et al. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase Cardiovasc Res 93 2012 120 129
73. C.L. Laffer, J.V. Gainer, M.R. Waterman, and et al. The T8590C polymorphism of CYP4A11 and 20-hydroxyeicoatetraenoic acid in essential hypertension Hypertension 51 2008 767 772
74. M.S. Lundblad, K. Stark, E. Eliasson, E. Oliw, and A. Rane Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2 C enzymes Biochem Biophys Res Commun 327 2005 1052 1057
75. N.C. Ward, I.-J. Tsai, A. Barden, and et al. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure Hypertension 51 2008 1393 1398